Search Results (3,624)

Background: Salmonella enterica, a major foodborne pathogen, poses a severe global public health threat. However, data regarding its carriage characteristics, transmission patterns, and association with intestinal microbiota in healthy populations of Xinjiang, China, remain insufficient, limiting the formulation of targeted salmonellosis prevention and control strategies. Methods: In this study, 31 Salmonella enterica strains isolated from more than 2000 healthy individuals in Urumqi were subjected to whole-genome sequencing to analyze serovars, antimicrobial resistance (AMR) genes, and virulence genes. Meanwhile, metagenomic sequencing was performed on 50 fecal samples (culture negative) from 2000 healthy individuals to investigate intestinal microbiota structure, Salmonella enterica prevalence, and related microbial taxa. Results: The results showed that 60% of samples (30/50) were positive by the read-based criterion (≥1000 Salmonella-specific reads), while the assembly-verified criterion (≥1000 reads and contigs > 1 kb) confirmed Salmonella-specific sequences in 12% (6/50). Among the 31 culture-confirmed isolates, Salmonella Typhimurium and Salmonella Paratyphi B were the dominant serovars, together accounting for 60%. All isolates harbored core virulence genes for Type III secretion system and adhesion factors, with low AMR gene carriage and no multidrug-resistant strains. Phylogenetic analysis showed that Urumqi-derived isolates were distributed across multiple genomic clusters, suggesting active inter-regional circulation of S. enterica within the available dataset. Salmonella enterica carriage did not affect gut microbial α-diversity but altered community composition, with Escherichia coli, Shigella flexneri, and Klebsiella pneumoniae as key associated taxa. Conclusions: This study found that Urumqi-derived isolates are widely distributed across genomic clusters in Xinjiang, with a unique local transmission chain identified, though definitive source attribution requires further geographically balanced sampling. Salmonella enterica carriage exhibited ecological niche synergy with intestinal Enterobacteriaceae, but did not significantly affect gut microbial diversity. Full article

Due to limitations in the use of antibiotics as feed additives to promote growth, the development of safe, effective, and environmentally friendly antibiotic alternatives is a critical and urgent research priority in animal nutrition and veterinary medicine. Plants contain abundant active substances, which are important sources for developing new feed additives or discovering new active substances. Ageratina adenophora (Spreng.) R.M.King & H.Rob. (A. adenophora) is an herb native to Central America and a globally invasive species that has spread across Asia, Australia, Africa, and other continents. Studies indicated that it possesses a complex chemical composition, with over 100 constituents identified, including terpenoids, flavonoids, and phenolic acids, which exhibit diverse biological activities, including antibacterial, antioxidant, insecticidal, acaricidal, anti-inflammatory, neuroprotective, antidiabetic, antitumor, and gut health regulation effects. However, it also possesses distinct toxicity, primarily targeting organs such as the intestines, liver, and spleen, causing tissue damage by activating specific signaling pathways. This may limit its utilization as a feed additive or in medical drug development. Therefore, this review systematically summarizes the botanical characteristics, geographic distribution, phytochemical composition, biological activities, and toxicological effects of A. adenophora. We also discussed its potential application and current challenges. We hope this review can promote its development and utilization as potential feed additives or medicinal resources. Full article

The intestinal barrier plays a critical role in maintaining gastrointestinal health and nutrient utilization in yaks. This study investigated the effects of dietary RPG level and RPT supplementation on colonic barrier function and microbial composition in yaks. Twenty-eight healthy male yaks (3 years old; 192.7 ± 4.52 kg) were assigned to a 2 × 2 factorial design with two dietary rumen-protected glucose (RPG) levels (1.0% or 3.0% of dietary DM) and two rumen-protected taurine (RPT) supplementation levels (5 or 20 g/animal/day) for 63 days. High-level RPG impaired colonic physical barrier function by reducing tight junction protein expression and microbial diversity, whereas high-level RPT mainly compromised chemical and immune barrier function by decreasing diamine oxidase activity, mucin-2, and secretory immunoglobulin A, accompanied by alterations in the colonic microbial community. Significant interactions between RPG and RPT were observed for several barrier- and microbiota-related indices. Overall, the effects of RPG and RPT on colonic health were dose-dependent, and moderate supplementation, particularly the combination of 1.0% dietary RPG and 5 g/day RPT, was the most effective in maintaining colonic barrier integrity and microbial homeostasis in yaks. Full article

This study evaluated the effects of dietary supplementation with 4% multispecies probiotic fermented broth (MPFB) on the apparent nutrient digestibility, carcass traits, serum immune indices, intestinal morphology, cecal microbiota, and thigh muscle nutrient composition in 815-strain yellow-feathered broilers. A total of 400 healthy 4-day-old broilers with similar body weight and a 1:1 sex ratio were randomly assigned to the control group with basal diet (CON) or the MPFB group with 4% MPFB. The results showed that MPFB significantly increased the apparent digestibility of crude protein and calcium (p < 0.05), and that of crude fiber and phosphorus (p < 0.01). The MPFB group has a higher thigh muscle yield and a lower abdominal fat yield (p < 0.05), while carcass yield tended to increase (p = 0.071). MPFB also elevated serum immunoglobulin M and interleukin-2 concentrations (p < 0.05), increased duodenal villus height (p < 0.05), reduced duodenal crypt depth (p < 0.05), and increased the villus height to crypt depth ratio in the duodenum, jejunum, and ileum (p < 0.05). Cecal microbiota analysis showed that MPFB significantly enriched Ruminococcus gauvreauii_group, Ruminococcus torques_group, and Turicibacter (p < 0.05), while Bacteroides tended to increase (p = 0.093), which were positively correlated with the improved nutrient digestibility and duodenal morphology. In thigh muscle, MPFB tended to increase cysteine content (p = 0.081), decreased C14:0 (p < 0.05), C16:0 and total saturated fatty acids (p < 0.01), increased C20:2 (p < 0.05), and tended to decrease C12:0 and C16:1 but increase C18:2n6c and total polyunsaturated fatty acid (p < 0.10). In conclusion, dietary supplementation with 4% MPFB improved nutrient utilization and selected carcass traits and modulated the thigh muscle fatty acid profile in yellow-feathered broilers, which are potentially associated with improved intestinal morphology and modulation of the cecal microbiota. Full article

Cigarette smoke exposure is a major preventable risk factor for respiratory disease and drives oxidative and inflammatory lung injury, highlighting the urgent need for safe, multi-target interventions beyond conventional anti-inflammatory therapy. Formononetin (FMN), a naturally occurring isoflavone with antioxidant, anti-inflammatory, and microbiota-modulating potential, may offer a dietary-botanical strategy against smoke-related pulmonary damage. This study evaluated FMN against cigarette smoke extract (CSE)-induced lung injury and explored its associations with intestinal barrier integrity, gut microbiota, taurine metabolism, SLC6A6 expression, and NF-κB activation. In a CSE-challenged mouse model, oral FMN, particularly at 70 mg/kg, improved body weight gain, reduced the lung index, attenuated pulmonary histopathological injury, restored GSH/GSSG and SOD, decreased MDA, and suppressed TNF-α, IL-1β, and IL-6 expression. FMN also ameliorated colonic injury and restored ZO-1 and occludin expression. Exploratory 16S rRNA sequencing and fecal metabolomics indicated FMN-associated alterations in gut microbial composition and metabolic profiles, with taurine and hypotaurine metabolism identified as a candidate pathway for further investigation. FMN further restored lung taurine content and SLC6A6 expression while inhibiting NF-κB activation. These findings suggest that FMN alleviates CSE-induced lung injury and that this improvement is associated with coordinated changes in gut microbiota composition, taurine metabolism, SLC6A6 expression, and NF-κB activation. Full article

Functional pet foods are increasingly being developed to support host metabolism and intestinal health. Lycium barbarum polysaccharide (LBP), a major bioactive component of goji berries, has been reported to possess antioxidant, anti-inflammatory, immunomodulatory, and gut microbiota-regulatory activities; however, its effects in domestic cats remain unclear. This study investigated the effects of dietary LBP supplementation on serum metabolomic profiles and gut microbiota in adult cats. Twenty-four healthy adult Chinese domestic cats (1.50 ± 0.50 years old; 3.70 ± 0.80 kg) were allocated to four groups using a body-weight-balanced procedure (n = 6 per group): a basal diet group (C) and basal diet supplemented with 0.2% (L), 0.3% (M), or 0.4% (H) LBP. After a 1-week adaptation period, the formal feeding trial lasted 8 weeks. Growth-related indices, health scores, hematological and serum biochemical parameters, untargeted serum metabolomics, and fecal 16S rRNA sequencing were evaluated. LBP supplementation did not significantly affect body weight, average daily feed intake, body condition score, fecal score, coat score, hematological indices, or serum biochemical parameters. Metabolomic analysis showed that LBP mainly affected lipid metabolism, unsaturated fatty acid biosynthesis, branched-chain amino acid metabolism, lysine degradation, and protein digestion and absorption-related pathways. Microbiota analysis showed changes in alpha diversity, community structure, and the relative abundance of taxa such as Olsenella, Bifidobacterium, Catenibacterium, Peptoclostridium, Collinsella, and Clostridium. Correlation analysis suggested potential associations between key bacterial genera and serum metabolites related to fatty acid and amino acid metabolism. Overall, dietary LBP altered serum metabolic signatures and gut microbial composition without causing adverse effects in adult cats, These exploratory findings require confirmation in larger feline studies and do not establish an optimal supplementation level. Full article

Cancer therapy-related cardiotoxicity has emerged as a major challenge in contemporary oncology, particularly in long-term survivors of childhood malignancies. Oxidative stress (OS)-induced cardiotoxicity represents a key mechanistic pathway underlying myocardial injury caused by numerous anti-neoplastic drugs, most notably anthracycline-based chemotherapy, while OS also critically contributes to radiotherapy-induced cardiotoxicity. Excessive reactive oxygen and nitrogen species generation promotes mitochondrial dysfunction, impaired calcium homeostasis, lipid peroxidation, endothelial injury, inflammatory activation, and cardiomyocyte apoptosis, ultimately leading to progressive cardiac remodeling and ventricular dysfunction. These processes are of particular concern in pediatric cancer survivors, especially children treated for leukemia, who face a substantially elevated lifetime risk of cardiovascular disease following treatment exposure. Increasing attention has, therefore, been directed toward nutritional strategies capable of modulating redox homeostasis and attenuating treatment-associated myocardial injury. Experimental and translational evidence suggests that selected dietary compounds and nutraceuticals, including polyphenols, omega-3 fatty acids, coenzyme Q10, selenium, antioxidant vitamins, nutrition-based epigenetic interventions and intestinal microbiota composition modulations may exert cardioprotective effects through preservation of mitochondrial integrity, enhancement of endogenous antioxidant defenses, and suppression of oxidative and inflammatory signaling pathways. Nevertheless, clinical implementation remains limited by insufficient standardization, heterogeneous study designs, and incomplete understanding of long-term efficacy and safety. This narrative review critically examines the molecular basis of the OS-induced cardiotoxicity and radiotherapy-induced cardiotoxicity and evaluates current evidence supporting nutrition-based cardioprotective interventions, with particular emphasis on pediatric leukemia survivors and the prevention of long-term cardiovascular complications following anticancer therapy. Full article

This study investigated the effects of glycerol monolaurate (GML) on the growth performance, physiological efficacy, intestinal structure, and microbiota of hybrid juvenile ♀ Epinephelus fuscoguttatus × ♂ E. lanceolatus. A total of 594 groupers were administered diets supplemented with 0, 2, 4, 6, 8, or 10 g/kg of GML over an 80-day period. The findings indicated that the group receiving 4 g/kg GML supplementation demonstrated significantly enhanced growth performance, as evidenced by increased weight gain, specific growth rate, and a reduced feed conversion ratio compared with the control and other experimental groups. This growth enhancement was associated with elevated catalase and glutathione levels, suggesting improved antioxidant capacity that may contribute to enhanced immune function. Furthermore, fish in the 4 g/kg group exhibited increased digestive enzyme activity and significantly improved intestinal morphology, characterized by thicker muscular layers and a greater fold width and height. Furthermore, compared with the control group, GML supplementation elevated the relative abundance of Proteobacteria while reducing that of Firmicutes at the phylum level. At the genus level, GML markedly suppressed the relative abundance of Mycoplasma and Vibrio. These compositional alterations are potentially linked to improved energy acquisition and a decreased risk of pathogenic infections. Collectively, these results reveal that GML acts as a promising functional feed additive to boost growth performance, optimize digestive capacity, and sustain intestinal structural integrity in hybrid grouper. Based on these results, the optimal GML supplementation dose was determined to be 4 g/kg, providing valuable insights into the role of GML in aquaculture practices for hybrid grouper. Full article

Ulcerative colitis is a chronic inflammatory bowel disease characterized by mucosal barrier disruption, dysregulated immune responses, and gut microbial imbalance. However, limitations of current therapies highlight the need for safe probiotic interventions. This study evaluated the preventive effects of fermented yak milk-derived Lacticaseibacillus paracasei CD12-1 on dextran sulfate sodium (DSS)-induced colitis in mice. The results showed that DSS caused body weight loss, an increased disease activity index, colon shortening, and severe histopathological injury. CD12-1 alleviated these abnormalities with differential effects across doses. The low-dose treatment produced the most comprehensive improvements in histopathological damage, goblet cell abundance, tight junction integrity, inflammatory cytokines, and short-chain fatty acids, whereas the high dose more effectively attenuated body weight loss. CD12-1 increased colonic ZO-1 and Occludin expression, reduced IL-1β, IL-6, and TNF-α levels, and increased IL-10. The low dose also elevated acetate and butyrate levels. Gut microbiota analysis showed that CD12-1 was associated with changes in the relative abundances of Lactobacillus, Bifidobacterium, Allobaculum, Akkermansia, and several inflammation-associated taxa. Correlation analysis associated Lactobacillus and Allobaculum with milder disease and improved barrier-related indicators, whereas Bacteroides and Sutterella were associated with greater disease severity and inflammation. Overall, CD12-1 alleviated DSS-induced colitis by improving intestinal barrier integrity and inflammatory homeostasis, accompanied by changes in microbial composition and short-chain fatty acid production. Full article

Dysregulation of the microbiota–gut–brain axis has been implicated in Parkinson’s disease (PD), and modulation of the intestinal microbiota may offer a complementary nutritional approach. This study evaluated the preventive attenuation of MPTP-induced PD-like abnormalities by Lactiplantibacillus plantarum SHOU LAC-1 and examined associated microbiota–gut–brain axis-related changes. Forty male C57BL/6J mice were allocated to Control, MPTP, L-DOPA, and SHOU LAC-1 groups (n = 10 per group). SHOU LAC-1 was orally administered at 1 × 10⁹ CFU per mouse per day for 42 days, with MPTP administered during the final 14 days; L-DOPA was administered during the MPTP-treatment period as a positive control. Motor performance and defecatory parameters, nigrostriatal TH and α-SYN immunoreactivity, neurotrophic-support-related gene expression, inflammatory markers, glial-cell-related gene expression, Nrf2-related antioxidant gene expression, colonic histopathology and tight-junction-related gene expression, gut microbiota composition, and serum metabolic profiles were assessed. Compared with MPTP-treated mice, SHOU LAC-1-treated mice showed better motor and defecatory performance, partial preservation of nigrostriatal TH immunoreactivity, reduced α-SYN immunoreactivity, increased neurotrophic-support-related gene expression, lower central and colonic inflammatory markers and glial-cell-related gene expression, increased Nrf2/HO-1/NQO1-related antioxidant gene expression, and comparatively better-preserved colonic morphology with higher tight-junction-related gene expression. 16S rRNA sequencing and untargeted serum metabolomics further showed that SHOU LAC-1 administration was accompanied by changes in gut microbial diversity and composition and serum metabolic profiles. Overall, under this preventive experimental design, SHOU LAC-1 administration was associated with attenuation of multiple MPTP-induced PD-like abnormalities, accompanied by changes in gut microbial and serum metabolic profiles. These preclinical findings are predominantly associative; causal relationships among microbial, metabolic, intestinal, and neurological changes remain to be established, and the translational relevance of SHOU LAC-1 requires further validation. Full article

Polysaccharides are well known for their immunomodulatory properties and gut microbiota-regulating functions; however, their digestive stability and structure-dependent biological mechanisms remain poorly understood. This study investigated the in vitro enzymatic resistance and intestinal regulatory effects of a novel L-β-galactoglucan (Mw 400–520 kDa) derived from Agrobacterium sp. FN01, and further evaluated the in vivo effects of its corresponding crude fermentation product on growth performance and intestinal metabolism in pigs. Twenty-seven-day-old weaned piglets were randomly allocated to three treatments, with 16 pens per treatment and 13 piglets per pen, and fed basal diets supplemented with 0, 200, or 400 mg/kg of the crude product. The results showed that L-β-galactoglucan exhibited strong resistance to pancreatic α-amylase and glucoamylase under the tested in vitro conditions, with minimal release of low-molecular-weight oligosaccharides during hydrolysis. The 400 mg/kg crude product supplementation significantly improved growth performance, reduced the feed-to-gain ratio, and increased the apparent total tract digestibility of dry matter, crude protein, crude fat, and gross energy (p < 0.05). In addition, dietary supplementation with this crude product increased intestinal microbial diversity, enriched Halalkalibacter urbisdiaboli, and increased colonic concentrations of isobutyrate and isovalerate (p < 0.05). Functional metagenomic analysis further revealed enhanced microbial carbohydrate metabolism and energy metabolic pathways. In conclusion, under the in vitro conditions tested in this study, the novel L-β-galactoglucan exhibited resistance to the two tested enzymes. In the pig trial, this polysaccharide improved growth performance and nutrient utilization, and modulated the intestinal microbial composition. These observations suggest that the fermentation product may be promising for animal feeding applications. Full article

Gut microbial metabolism links intestinal ecology with systemic physiology and neural pathology, but its effects vary across disease stage, tissue compartment, and host background. This review uses Alzheimer’s disease (AD) as the principal model and compares selected features with Parkinson’s disease (PD) and amyotrophic lateral sclerosis (ALS). Across the AD continuum, fermentation-related changes appear in prodromal cohorts, whereas broader alterations in amino acid products, host–microbial co-metabolites, bile acids, and lipids accompany mild cognitive impairment and dementia. These group-level patterns do not constitute a fixed patient trajectory. Microbial production, intestinal absorption, hepatic conversion, renal clearance, barrier integrity, and tissue-specific receptors jointly determine biological exposure. Experimental studies connect short-chain fatty acids and indole derivatives with epithelial and neuroimmune homeostasis, while imidazole propionate, trimethylamine N-oxide, selected kynurenine products, and remodeled bile acid pools engage vascular, inflammatory, amyloid, or tau-related pathways. Cerebral pathology can also remodel the intestinal ecosystem, creating reciprocal feedback. Apolipoprotein E4 modifies lipid handling, vascular permeability, and immune responses, helping to explain why comparable metabolic profiles may carry different consequences among individuals. Translation therefore requires more than a change in community composition. Trials must verify microbial function, metabolite target engagement, AD biomarker response, and clinical benefit in appropriately stratified participants. Shared pathways in PD and ALS provide comparison points, but disease-specific cells, proteinopathies, and treatment exposures constrain direct transfer of AD-derived targets. Full article

Objective: This study aimed to develop and optimize a rapid, eco-friendly microwave-assisted extraction (MAE) process for recovering total phenolic content (TPC) and total flavonoid content (TFC) from garlic (Allium sativum L.), while evaluating the predictive performance of response surface methodology (RSM) versus artificial neural networks (ANNs) and assessing the in vitro gastrointestinal stability of key polyphenols. Methodology: A four-factor, three-level central composite design (CCD) was implemented to evaluate the effects of extraction time, temperature, ethanol concentration, and solvent-to-solid ratio. A second-order polynomial RSM model was benchmarked against a 4-10-2 multilayer perceptron ANN trained by backpropagation. Optimal conditions were derived using the Derringer–Suich desirability function and confirmed experimentally. Individual polyphenols were profiled via LC-MS/MS and monitored across simulated oral, gastric, and intestinal digestion phases. Principal Results: The ANN model demonstrated superior predictive performance (R² = 0.9999 training, 0.9974 validation, 0.9939 testing) compared to the RSM model (R² = 0.9721 for TPC and 0.9925 for TFC). Experimental validation under optimal conditions—1.50 min, 55 °C, 75% ethanol, and a 29 mL/g ratio—yielded a TPC of 2.487 mg GAE/g FW and a TFC of 21.356 mg QUE/g FW. During simulated gastrointestinal digestion, significant degradation occurred during the intestinal phase, resulting in low final recoveries for gallic acid (16.9%), caffeic acid (19.9%), and luteolin (22.6%). Conclusions: MAE coupled with ANN modeling provides a highly accurate, rapid, and green extraction strategy for garlic polyphenols. However, the marked degradation of target compounds during intestinal digestion highlights the necessity of encapsulation or protective delivery systems to preserve their biological functionality in food applications. Full article

Clostridioides difficile infection (CDI) remains a major cause of antibiotic-associated diarrhea, with recurrence largely driven by disruption of the gut microbiota and impaired colonization resistance. Bile acids have emerged as key mediators in this process, as primary conjugated bile acids promote C. difficile spore germination, whereas microbiota-derived secondary bile acids can inhibit germination, vegetative growth, and toxin activity. Diet further modulates CDI susceptibility by shaping microbial composition, short-chain fatty acid production, bile acid transformation, epithelial barrier integrity, and intestinal inflammation. Western-style diets, and low fiber intake, may favor dysbiosis and a bile acid profile permissive to CDI, while fiber-rich and Mediterranean-type dietary patterns may support beneficial anaerobes, microbial metabolites, and mucosal resilience. This narrative review summarizes current evidence on the bile acid–diet–microbiome axis in CDI pathogenesis, recurrence, and therapy. It also discusses standard treatment limitations, microbiome-based therapeutics, dietary interventions, and emerging bile acid-targeted strategies. Understanding this axis may support future precision approaches aimed not only at suppressing C. difficile, but also at restoring microbiota function and durable colonization resistance. Full article

The fact that the population is getting older has greatly increased the occurrence of cognitive decline and neurodegenerative diseases, underlining the importance of having reliable biomarkers that can measure biological aging before irreversible neurological damage takes place. New evidence shows that brain aging is not just the result of changes within neurons themselves but is also greatly affected by the gut microbiota via immune, metabolic, endocrine, and neurovascular signaling. This review brings together the existing knowledge about biomarkers of biological aging-such as telomere shortening, epigenetic clocks, oxidative stress, inflammation, cellular senescence, and metabolic dysfunction-as well as established cognitive biomarkers obtained from neuroimaging, cerebrospinal fluid, blood, genetic evaluations, and neuropsychological tests. We also point out that changes associated with age in the composition of the gut microbiota and the metabolites it produces are becoming more and more involved in the mechanisms connecting intestinal dysbiosis, dysfunction of the blood-brain barrier (BBB), neuroinflammation, and age-related cognitive decline. Through this approach of combined and complementary biomarker systems, we hypothesize that the gut microbiota has emerged as a central regulator of biological and cognitive aging and may provide a useful source for development of biomarkers of cognitive resilience and risk of neurodegenerative diseases. Lastly, we consider microbiome-based interventions, including probiotics, prebiotics, dietary changes, fecal microbial transplant, and new treatment modalities derived from molecular studies, as possible approaches to the prevention and management of age-related cognitive decline. Collectively, this review provides a comprehensive framework linking aging biology, microbiome science, and cognitive biomarkers to advance biomarker-driven precision medicine for healthy brain aging. Full article